171 related articles for article (PubMed ID: 24004884)
1. Spatial-temporal event adaptive characteristics of nanocarrier drug delivery in cancer therapy.
Kong M; Park H; Cheng X; Chen X
J Control Release; 2013 Nov; 172(1):281-291. PubMed ID: 24004884
[TBL] [Abstract][Full Text] [Related]
2. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
Chakraborty S; Dhakshinamurthy GS; Misra SK
J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
[TBL] [Abstract][Full Text] [Related]
3. How are we applying nanogel composites in biomedicine?
Kar M; Molina M; Calderón M
Nanomedicine (Lond); 2017 Jul; 12(14):1627-1630. PubMed ID: 28635377
[No Abstract] [Full Text] [Related]
4. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
[TBL] [Abstract][Full Text] [Related]
5. A smart polymeric platform for multistage nucleus-targeted anticancer drug delivery.
Zhong J; Li L; Zhu X; Guan S; Yang Q; Zhou Z; Zhang Z; Huang Y
Biomaterials; 2015 Oct; 65():43-55. PubMed ID: 26142775
[TBL] [Abstract][Full Text] [Related]
6. Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review.
Ramasamy T; Ruttala HB; Gupta B; Poudel BK; Choi HG; Yong CS; Kim JO
J Control Release; 2017 Jul; 258():226-253. PubMed ID: 28472638
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs.
Fouladi F; Steffen KJ; Mallik S
Bioconjug Chem; 2017 Apr; 28(4):857-868. PubMed ID: 28201868
[TBL] [Abstract][Full Text] [Related]
8. Artificial Molecular Machines in Nanotheranostics.
Yu G; Yung BC; Zhou Z; Mao Z; Chen X
ACS Nano; 2018 Jan; 12(1):7-12. PubMed ID: 29283247
[TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive polymeric nanoparticles for nanomedicine.
Crucho CI
ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
[TBL] [Abstract][Full Text] [Related]
10. Programmable nanomedicine: synergistic and sequential drug delivery systems.
Pacardo DB; Ligler FS; Gu Z
Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
[TBL] [Abstract][Full Text] [Related]
11. Stimuli-Responsive Programmed Specific Targeting in Nanomedicine.
Wang S; Huang P; Chen X
ACS Nano; 2016 Mar; 10(3):2991-4. PubMed ID: 26881288
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers with tunable surface properties to unblock bottlenecks in systemic drug and gene delivery.
Zou H; Wang Z; Feng M
J Control Release; 2015 Sep; 214():121-33. PubMed ID: 26208425
[TBL] [Abstract][Full Text] [Related]
13. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
14. Functional liposomes in the cancer-targeted drug delivery.
Tila D; Ghasemi S; Yazdani-Arazi SN; Ghanbarzadeh S
J Biomater Appl; 2015 Jul; 30(1):3-16. PubMed ID: 25823898
[TBL] [Abstract][Full Text] [Related]
15. Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer.
Liu Y; Xu CF; Iqbal S; Yang XZ; Wang J
Adv Drug Deliv Rev; 2017 Jun; 115():98-114. PubMed ID: 28396204
[TBL] [Abstract][Full Text] [Related]
16. pH-responsive dendritic core-multishell nanocarriers.
Fleige E; Achazi K; Schaletzki K; Triemer T; Haag R
J Control Release; 2014 Jul; 185():99-108. PubMed ID: 24768791
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine in cancer treatment.
Yih TC; Wei C
Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
[No Abstract] [Full Text] [Related]
18. Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release.
Liu J; Cabral H; Mi P
Adv Drug Deliv Rev; 2024 Apr; 207():115239. PubMed ID: 38437916
[TBL] [Abstract][Full Text] [Related]
19. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
